Company delivered ROE of 12.93% in year ending Mar 31, 2024 outperforming its 5 year avg. of 10.32%. (Source: Consolidated Financials)
Windlas Biotech Share Price
Windlas Biotech Share P...
Windlas Biotech share price insights
Company's annual revenue growth of 23.21% outperformed its 3 year CAGR of 14.22%. (Source: Consolidated Financials)
Stock gave a 3 year return of 133.52% as compared to Nifty Smallcap 100 which gave a return of 91.39%. (as of last trading session)
Company has spent less than 1% of its operating revenues towards interest expenses and 13.86% towards employee cost in the year ending Mar 31, 2024. (Source: Consolidated Financials)
Windlas Biotech Ltd. share price moved down by -3.19% from its previous close of Rs 839.35. Windlas Biotech Ltd. stock last traded price is 812.65
Share Price Value Today/Current/Last 812.65 Previous Day 839.35
Key Metrics
PE Ratio (x) | 28.50 | ||||||||||
EPS - TTM (₹) | 28.52 | ||||||||||
MCap (₹ Cr.) | 1,698.46 | ||||||||||
Sectoral MCap Rank | 67 | ||||||||||
PB Ratio (x) | 3.90 | ||||||||||
Div Yield (%) | 0.00 | ||||||||||
Face Value (₹) | 5.00 | ||||||||||
Beta Beta
| - | ||||||||||
VWAP (₹) | 815.70 | ||||||||||
52W H/L (₹) |
Windlas Biotech Share Price Returns
1 Day | -3.19% |
1 Week | -2.17% |
1 Month | 5.63% |
3 Months | 30.13% |
1 Year | 127.6% |
3 Years | 133.52% |
5 Years | N.A. |
Windlas Biotech News & Analysis
Windlas Biotech Share Recommendations
No Recommendations details available for this stock.
Check out other stock recos.
Windlas Biotech Financials
Income (P&L)
Balance Sheet
Cash Flow
Ratios
Insights
Beating 3 Yr Revenue CAGR
Company's annual revenue growth of 23.21% outperformed its 3 year CAGR of 14.22%. (Source: Consolidated Financials)Employee & Interest Expense
Company has spent less than 1% of its operating revenues towards interest expenses and 13.86% towards employee cost in the year ending Mar 31, 2024. (Source: Consolidated Financials)
Quarterly | Annual Jun 2024 Mar 2024 Dec 2023 Sep 2023 Jun 2023 Total Income 179.29 175.73 165.38 155.91 147.41 Total Income Growth (%) 2.03 6.26 6.07 5.77 3.05 Total Expenses 160.48 152.82 145.27 137.32 130.83 Total Expenses Growth (%) 5.02 5.20 5.79 4.96 2.34 EBIT 18.80 22.91 20.11 18.60 16.58 EBIT Growth (%) -17.92 13.91 8.15 12.18 9.02 Profit after Tax (PAT) 13.48 16.99 15.10 14.03 12.07 PAT Growth (%) -20.68 12.55 7.60 16.30 5.43 EBIT Margin (%) 10.49 13.04 12.16 11.93 11.25 Net Profit Margin (%) 7.52 9.67 9.13 9.00 8.18 Basic EPS (₹) 6.47 8.17 7.26 6.75 5.79 All figures in Rs Cr, unless mentioned otherwise
Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 Total Assets 626.21 528.98 491.01 296.12 338.49 Total Assets Growth (%) 18.38 7.73 65.81 -12.52 13.52 Total Liabilities 176.27 126.70 96.23 97.00 128.83 Total Liabilities Growth (%) 39.12 31.66 -0.79 -24.70 23.17 Total Equity 449.94 402.27 394.78 199.12 209.66 Total Equity Growth (%) 11.85 1.90 98.26 -5.03 8.30 Current Ratio (x) 2.51 2.92 4.02 2.08 1.34 Total Debt to Equity (x) 0.00 0.00 0.02 0.15 0.11 Contingent Liabilities 0.00 14.11 3.25 - - All figures in Rs Cr, unless mentioned otherwise
Insights
Increase in Cash from Investing
Company has used Rs 92.07 cr for investing activities which is an YoY increase of 552.5%. (Source: Consolidated Financials)
Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 Net Cash flow from Operating Activities 108.96 60.97 9.13 11.45 25.01 Net Cash used in Investing Activities -92.07 -14.11 -154.58 -20.20 -14.34 Net Cash flow from Financing Activities -15.29 -43.74 130.09 0.78 -5.44 Net Cash Flow 1.60 3.12 -15.36 -2.15 5.22 Closing Cash & Cash Equivalent 5.29 3.69 0.57 15.93 18.08 Closing Cash & Cash Equivalent Growth (%) 43.46 546.67 -96.42 -11.88 40.63 Total Debt/ CFO (x) 0.00 0.01 0.67 2.64 0.89 All figures in Rs Cr, unless mentioned otherwise
Insights
ROE Outperforming 5 Year Average
Company delivered ROE of 12.93% in year ending Mar 31, 2024 outperforming its 5 year avg. of 10.32%. (Source: Consolidated Financials)
Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 Return on Equity (%) 12.93 10.59 9.64 7.95 7.73 Return on Capital Employed (%) 17.20 14.18 11.83 22.11 16.25 Return on Assets (%) 9.29 8.05 7.75 5.34 4.78 Interest Coverage Ratio (x) 82.93 89.07 41.73 34.74 13.72 Asset Turnover Ratio (x) 1.09 1.01 1.18 144.40 97.15 Price to Earnings (x) 18.32 11.06 12.03 - - Price to Book (x) 2.37 1.17 1.16 - - EV/EBITDA (x) 11.29 6.36 5.92 - - EBITDA Margin (%) 14.52 13.68 12.69 13.51 13.36
Windlas Biotech Peer Comparison
Windlas Biotech Stock Performance
Ratio Performance
Insights
Stock Returns vs Nifty Smallcap 100
Stock gave a 3 year return of 133.52% as compared to Nifty Smallcap 100 which gave a return of 91.39%. (as of last trading session)
Choose from Peers
Choose from Stocks
- There’s no suggested peer for this stock.
- 1D
- 1W
- 1M
- 3M
- 6M
- 1Y
- 5Y
Loading...Insights
Stock Returns vs Nifty Smallcap 100
Stock gave a 3 year return of 133.52% as compared to Nifty Smallcap 100 which gave a return of 91.39%. (as of last trading session)
See All Parameters
MF Ownership
MF Ownership details are not available.
Corporate Actions
Windlas Biotech Board Meeting/AGM
Windlas Biotech Dividends
- Others
Meeting Date Announced on Purpose Details Aug 13, 2024 Aug 02, 2024 Board Meeting Quarterly Results May 20, 2024 May 21, 2024 Board Meeting Audited Results & Dividend Feb 08, 2024 Jan 30, 2024 Board Meeting Quarterly Results Nov 08, 2023 Oct 30, 2023 Board Meeting Quarterly Results Sep 12, 2023 Aug 17, 2023 AGM Rs.4.0000 per share(80%)Final Dividend & A.G.M. Type Dividend Dividend per Share Ex-Dividend Date Announced on Final 80% 4.0 Sep 05, 2023 May 05, 2023 Final 70% 3.5 Sep 09, 2022 May 12, 2022 Final 110% 5.5 - May 21, 2024 No other corporate actions details are available.
About Windlas Biotech
Executives
Auditors
- VD
Vivek Dhariwal
Chairman & Ind.DirectorHWHitesh Windlass
Managing DirectorMKManoj Kumar Windlass
Joint Managing DirectorKGKomal Gupta
CEO & CFOShow More - S S Kothari Mehta & Co
Industry
Key Indices Listed on
-
Address
40/1, Mohabewala Industrial Area,Dehradun, Uttarakhand/Uttaranchal - 248110
More Details
FAQs about Windlas Biotech share
- 1. What's the Windlas Biotech share price today?As on 29 Aug, 2024, 03:51 PM IST Windlas Biotech share price was down by 3.19% basis the previous closing price of Rs 844.35. Windlas Biotech share price was Rs 812.65. Return Performance of Windlas Biotech Shares:
- 1 Week: Windlas Biotech share price moved down by 2.17%
- 3 Month: Windlas Biotech share price moved up by 30.13%
- 6 Month: Windlas Biotech share price moved up by 61.43%
- 2. What is the CAGR of Windlas Biotech?The CAGR of Windlas Biotech is 10.21.
- 3. What is the market cap of Windlas Biotech?Windlas Biotech share has a market capitalization of Rs 1,698.46 Cr. Within General sector, it's market cap rank is 67.
- 4. Is Windlas Biotech giving dividend?Windlas Biotech Ltd. announced an equity dividend of 80% on a face value of 5.0 amounting to Rs 4 per share on 05 May 2023. The ex dividend date was 05 Sep 2023.
- 5. Who's the chairman of Windlas Biotech?Vivek Dhariwal is the Chairman & Ind.Director of Windlas Biotech
- 6. How can I quickly analyze Windlas Biotech stock?Key Metrics for Windlas Biotech are:
- PE Ratio of Windlas Biotech is 28.50
- Price/Sales ratio of Windlas Biotech is 1.69
- Price to Book ratio of Windlas Biotech is 3.90
- 7. Who is the Chief Executive Officer of Windlas Biotech?Komal Gupta is the CEO & CFO of Windlas Biotech
- 8. What are the returns for Windlas Biotech share?Return Performance of Windlas Biotech Shares:
- 1 Week: Windlas Biotech share price moved down by 2.17%
- 3 Month: Windlas Biotech share price moved up by 30.13%
- 6 Month: Windlas Biotech share price moved up by 61.43%
- 9. Which are the key peers to Windlas Biotech?Top 10 Peers for Windlas Biotech are Fairchem Organics Ltd., Motisons Jewellers Ltd., Sigachi Industries Ltd., Borosil Scientific Ltd., Platinum Industries Ltd., BLS E-Services Ltd., Popular Vehicles and Services Ltd., Veranda Learning Solutions Ltd., Divgi Torqtransfer Systems Ltd. and Aeroflex Industries Ltd.
- 10. What are the Windlas Biotech quarterly results?Total Revenue and Earning for Windlas Biotech for the year ending 2024-03-31 was Rs 644.42 Cr and Rs 58.19 Cr on Consolidated basis. Last Quarter 2024-06-30, Windlas Biotech reported an income of Rs 179.29 Cr and profit of Rs 13.48 Cr.
- 11. What is the PE & PB ratio of Windlas Biotech?The PE ratio of Windlas Biotech stands at 29.43, while the PB ratio is 3.88.
- 12. What is Windlas Biotech's 52 week high / low?In last 52 weeks Windlas Biotech share had a high price of Rs 899.85 and low price of Rs 311.60
- 13. Who are the key owners of Windlas Biotech stock?
- Promoter holding have gone down from 62.82 (30 Sep 2023) to 62.51 (30 Jun 2024)
- Domestic Institutional Investors holding have gone down from 11.48 (30 Sep 2023) to 10.35 (30 Jun 2024)
- Foreign Institutional Investors holding has gone up from 0.8 (30 Sep 2023) to 1.58 (30 Jun 2024)
- Other investor holding has gone up from 24.9 (30 Sep 2023) to 25.56 (30 Jun 2024)
Trending in Markets
Windlas Biotech Quick Links
Equity Quick Links
More from Markets
IPOStock market news
Budget 2022 Live Updates
Cryptocurrency
Currency converter
NSE holiday list
DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).
DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.
By using this site, you agree to the Terms of Service and Privacy Policy.